GJB2 and cancer: Furthermore, we analyzed the prognostic value of GJB2 in pan-cancers and the association of GJB2 with the clinical pathological stages, immune checkpoint (ICP) genes, tumor mutation burden (TMB), microsatellite instability (MSI), and neoantigens.